Stock Doctor testimonials
Jim Brownlee Stock Doctor client since 2004Hear what Jim has to say about the Stock Doctor methodology and software.
1 min 57 sec
Michael Craig Stock Doctor client since 2004Hear what Michael has to say about the Stock Doctor methodology and software.
2 min 19 sec
Our clients tell us what they think about Stock DoctorHear what our clients have to say about the Stock Doctor methodology and software.
1 min 0 sec
User Group Meeting (UGM) client testimonials.Hear what our clients had to say at the 2009 Melbourne UGM in November.
1 min 0 sec
Stock Doctor is an invaluable tool for selecting undervalued high quality stocks.
Gary Burns  Stock Doctor subscriber 2010 - present
I find that Stock Doctor has considerably reduced my time spent on identifying stocks for investment. Stock Doctor gives me the confidence to buy.
Mike Champion  Stock Doctor subscriber 2010 - present
As a long term user of Stock Doctor it has given me the ability to focus my in-depth analysis on only the most financially stable and growing companies, saving me a tremendous amount of time and effort.
Gary Temczuk  Stock Doctor subscriber 2005 - present
We rely on Stock Doctor for reviewing whether a company has got the right cashflow and balance sheet characteristics to remain in our portfolios. Stock Doctor will weed out 70% to 80% of companies that look promising to us on the first run. It leaves you with companies that may provide good prospects and earnings potential without all the balance sheet issues.
Ivor Ries  Head of Research E.L. & C. Baillieu Stockbroking
I'm in the stockmarket to make money - not wade through the mountains of information that I'm constantly bombarded with. This doesn't mean I can afford to ignore information so I use powerful investment tools like Stock Doctor by Lincoln. I have to trust the tools I use in the stockmarket and Stock Doctor distills the important data I need without tainting it.
Alan Hull  Share Trader and Bestselling author of 'Active Investing' by Wrightbooks
With access to up to date fundamental information, I am now more confident in making sound investment decisions. I am in front despite current market conditions.
Peter Ochota  Stock Doctor subscriber 2009 - present
I am so impressed with the direction you are taking with SD I have recently re-joined for 5 years as a Platinum.
In my opinion you are heading in the direction you must to protect and grow the business and continue to offer both the best service and value.
Well done from a completely satisfied customer.
Jeff  Stock Doctor subscriber 2010 - present
Lincoln is an outstanding example of first class customer service. I have had several brief contacts in the relatively short time I have been a subscriber and each one has been exemplary. I am a customer for life.
Peter Lynn  Stock Doctor subscriber 2010 - present
Stock Doctor is definitely the best available for analysis of fundamental data in Australia, particularly the ready access to analysts and rapid update of information as it is made available to the market.
Peter Hallsworth  Stock Doctor subscriber 2007 - present
Stock Doctor's methodology gives a degree of confidence when making equity investment decisions that I have not experienced before.
Colin Sharpe  Stock Doctor subscriber 2002 - present
Stock Doctor is simple to understand and gives me the ability to select the strongest stocks fundamentally to buy. This results regularly, for me, in outperformance of the index.
Mark Barnes  Stock Doctor subscriber 2008 - present
Stock Doctor suits my needs because it is based on providing sound fundamental company analysis which is presented in a format that is easily understood and on which I can confidently make my own investment decisions.
Geoff Hooper  Stock Doctor subscriber 2009 - present
Stock Doctor has allowed me to grow my portfolio every year since subscribing, even through the Global Financial Crisis. Stock Doctor's tools, together with the analysis provided by the Analyst team makes Stock Doctor an essential part of my investment process.
David Cutler  Stock Doctor subscriber 2003 - present
Lincoln Indicators are innovators in the retail investment market. Great initiatives, well executed. I'm a fan of their family style customer relationship and service model, Lincoln are a company with whom it's always a pleaser to do business.
Helen Mair  Stock Doctor subscriber 2002 - present
For rapid fundamental information with intelligent analysis and interpretation, Stock Doctor is a most valuable resource. It is of great assistance in determining which stocks suit a whole range of portfolio styles.
Donald Swain  Stock Doctor subscriber 2006 - present
Lincoln is personified by its integrity. Integrity of its product, integrity of its people and integrity of its management. For the information it provides investors, its product is fundamentally cheap at the current price. No serious investor in Australia should operate in the Australian market without Stock Doctor.
Thomas Boyle  Stock Doctor subscriber 2005 - present
I am very pleased with the ease of using Stock Doctor and the level of support and training available with flexibility to suit my timetable.
Peter James  Stock Doctor subscriber 2008 - present
I initially subscribed to Stock Doctor in 2003. The first scan I did showed that over half my portfolio was in unhealthy stocks. I had spent hours poring over Annual Reports and now I have the results I need in a matter of seconds. Stock Doctor has paid for itself for as long as I subscribe, it is an essential part of my investing in the stock market and will continue to be for a long time.
Alex Dean  Stock Doctor subscriber 2003 - present
Stock Doctor is the most effective tool I have found for selecting stocks. In addition the support provided via email, phone access, workshop sessions and the Investors' Network is nothing less than fantastic. And for a highly scientific program, the company has always had a 'family' feel to it, right from my first contact.
Gavin Swallow  Stock Doctor subscriber 2009 - present
Liability
Testimonials are provided by third parties for information purposes only and are not intended to be financial product advice. Please refer to Terms of use


